This issue describes the Russian commercial pharmacy market in September 2007 and in the III quarter of 2007.
For the period of January-September 2007 drugs commercial market volume amounted to $3.956 billion (in pharmacy purchasing prices) which is 20.19% higher than the year before. Drugs commercial market amounted to $490 mln in September 2007 which is 9.6% higher than in August and 24.5% higher than in September 2006. Growth in rubles is +8.4% to August 2007 and +18% to September 2006.
The weighted average price per drug unit amounted to 38.84 rubles ($1.53).
According to Laspeyres index prices on the commercial pharmacy market increased by 1.9% in rubles and by 0.7% in dollars in September 2007 compared to the previous month.
Structure of drugs from different price categories stayed almost the same in the III quarter of 2007.
Domestic and imported drugs ratio in value terms stayed the same in the III quarter 2007 compared to that of 2006: domestic drugs cover 24%, while imported ones — 76%.
In the III quarter of 2007 Rx drugs share increased by 1% in value terms and amounted to 60%.
Sanofi-Aventis leads TOP-10 drugs manufactures. Pharmstandard moved from 5th to 2nd position, having increased its sales by 67%.
A TOP-10 drug manufacturers of the III quarter of 2007 differs from the TOP-10 of September 2007. Because III quarter covers summer and autumn months, i.e. the period when seasonal diseases change. So, TOP companies and brands also changes. TOP-3 drug manufacturers are: Sanofi-Aventis, Berlin-Chemie /A.Menarini/ and Pharmstandard.
The leading drug brands in September 2007 are Arbidol, Teraflu and Viagra.
In September 2007 Russian NS (nutritional supplements) pharmacy market volume amounted to $26 mln which is 11% higher than in previous month and 24.9% higher than in September 2006. At that in unit terms NS market volume amounted to 18 mln units (+18.4% to August 2007 and + 24.9% to September 2006).
The weighted average cost per NS unit amounted to 39.94 rubles ($1.49).
TOP-10 NS manufacturers cover almost a half of the commercial market in September 2007 (48.29%). Also vitamin mineral complexes become more popular: Gerimax Energy and AlphaVIT.
Drug import volume amounted to $640 mln in August 2007 (+8.1% to July 2007; +26.6% to August 2006). Berlin-Chemie /A.Menarini/ (4.8%) is the leading manufacturer by drug import volume in August 2007.
All market reviews by DSM Group are available on the page Analytics.
